Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2000-08-18
2003-12-16
Fredman, Jeffrey (Department: 1637)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S320100, C435S410000, C435S468000, C800S295000
Reexamination Certificate
active
06664384
ABSTRACT:
BACKGROUND OF THE INVENTION
The invention relates to methods of manipulating gene expression in plants.
The ability to manipulate gene expression provides a means of producing new characteristics in transformed plants. There are many situations in which high or increased levels of gene expression may be desired. For example, it is desirable to increase production of a protein that itself maximizes the disease resistance, yield, flavor, or any other commercially important attribute of a plant. Similarly, the regulation of endogenous gene expression by the exogenous expression of antisense, ribozyme RNA, or transgene silencing may result in more valuable plants or plant products. The enhancement of expression, through the use of the invention disclosed herein, would facilitate these possibilities.
SUMMARY OF THE INVENTION
We have discovered duplicated enhancer domains for use in the enhancement of gene expression in transgenic plants. The duplicated enhancer domains have a plurality of the repetitive units of one or more enhancers derived from cassava vein mosaic virus (CsVMV). The duplicated enhancer domains are preferably accompanied by a promoter that includes an RNA polymerase binding site and an mRNA initiation site. Expression constructs, including a duplicated enhancer domain and a promoter, provide for enhanced expression of a desired trait compared to that achieved with the promoter in the absence of the duplicated enhancer domain.
Accordingly, in a first aspect, the invention features an enhancer cassette that includes a duplicated enhancer domain derived from a cassava vein mosaic virus.
Preferably, the enhancer cassette includes a component having the formula (X-Y)
n
, wherein X corresponds to the enhancer domain derived from a cassava vein mosaic virus, Y is an intervening spacer domain having a sequence that is placed between enhancer domains and is typically between about zero and about five hundred nucleotides inclusive (preferably between zero and about one hundred nucleotides and, more preferably, between zero and thirty nucleotides), and n is an integer between 2 and 8 inclusive. In preferred embodiments, the enhancer domain (X) has a sequence that includes nucleotides 1 to about 261 of SEQ ID NO: 1, nucleotides 1 to about 332 of SEQ ID NO: 1, or nucleotides of about 262 to about 332 of SEQ ID NO: 1. Preferably, in the formula of the first aspect, (X-Y)
n
, n is 2. The spacer domains (Y) can be identical or different. For example, an enhancer cassette having the formula (X-Y)
3
can have three different spacer sequences.
In a related aspect, the invention features an expression construct including the enhancer cassette of the first aspect and a second component that includes a promoter having an RNA polymerase binding site and an mRNA initiation site. A preferred promoter is a cassava vein mosaic virus promoter, such as one included in the nucleotides from about 333 to about 444 of SEQ ID NO: 1. The promoter can also be a heterologous promoter (for example, a Ti-plasmid promoter such as the T-DNA gene 5 or 7 promoter). In preferred embodiments, the expression construct includes a sequence corresponding to SEQ ID NO: 2. (FIG.
4
A), SEQ ID NO: 3 (FIG.
4
B), SEQ ID NO: 4 (FIG.
4
C), SEQ ID, NO: 5 (FIG.
4
D), or SEQ ID NO: 6 (FIG.
4
E).
The expression construct may further include, as a third component, a nucleic acid molecule of interest, wherein the first, second, and third components are operably linked so that the nucleic acid molecule is transcribed. The third component of the construct can encode a protein providing disease or insect resistance, an antisense RNA, a selectable marker (e.g., GUS, GFP, and the like), a non-translatable RNA molecule, or any protein or RNA that improves or results in a desired attribute.
This three-component expression construct of the present invention, when placed in a transcription medium capable of supporting transcription, typically results in increased transcription of the nucleic acid molecule relative to transcription of the nucleic acid molecule operably linked to an expression construct that has only one CsVMV enhancer domain.
In related aspects, the invention also features vectors and cells that include the enhancer cassette of the first aspect. Preferably, the cell is a eukaryotic cell, and, more preferably, a plant cell (e.g., from a monocotylenous plant or a dicotylenous plant).
In another related aspect, the invention also features a transgenic plant that includes the enhancer cassette of the first aspect.
In yet another related aspect, the invention features a method for expressing a nucleic acid molecule. The method includes transforming a cell (for example, a plant cell) with an expression construct that includes (a) a first component having the formula (X-Y)
n
, wherein X corresponds to the enhancer domain derived from a cassava vein mosaic virus, Y is an intervening spacer domain having a sequence that is placed between enhancer domains and is typically between about zero and about five hundred nucleotides inclusive (preferably between zero and about one hundred nucleotides and, more preferably, between zero and thirty nucleotides), and n is an integer between 2 and 8 inclusive; (b) a second component that includes a promoter (e.g., an RNA polymerase binding, site and an mRNA initiation site); and (c) a third component that includes the nucleic acid molecule to be expressed, wherein the first, second, and third components are operably linked so that the nucleic acid molecule is transcribed. In preferred embodiments, the enhancer domain (X) consists of a sequence that includes nucleotides from about 1 to about 261 of SEQ ID NO: 1, nucleotides from about 1 to about 332 of SEQ ID NO: 1, and nucleotides from about 262 to about 332 of SEQ ID NO: 1. Preferably, in the formula of the third aspect, (X-Y)
n
, n is 2.
The promoter can be any promoter that is functional in the transformed cell, but preferably is a cassava vein mosaic virus promoter (e.g. one included in nucleotides from about 333 to about 444 of SEQ ID NO: 1).
The third component of the expression construct can encode a protein providing disease or insect resistance, an antisense RNA, a selectable marker (e.g., GUS, GFP, and the like), or any protein or RNA including but not limited to a nontranslatable RNA or any RNA molecule capable of inducing transgene silencing.
As used herein, by “nucleic acid” is meant either DNA or RNA. A “nucleic acid molecule” may be a single-stranded or double-stranded polymer of deoxyribonucleotide or ribonucleotide bases. Unless otherwise specified, the left hand direction of the sequence of a single-stranded nucleic acid molecule is the 5′ end, and the left hand direction of double-stranded nucleic molecule is referred to as the 5′ direction.
By “promoter” is meant a region of nucleic acid, upstream from a translational start codon, which is involved in recognition and binding of RNA polymerase and other proteins to initiate transcription. A “plant promoter” is a promoter capable of initiating transcription in a plant cell, and may or may not be derived from a plant cell. A “CsVMV promoter” is one derived from the promoter region of a CsVMV genome and that, when operably linked to a heterologous. nucleic acid molecule, is capable of initiating transcription of that molecule when present in a transcription medium capable of supporting transcription, such as in a plant cell, a plant, or in vitro.
Exemplary transcription media include, for example, a plant cell, plant protoplasts, or other plant tissue culture configurations, non-differentiated plant cells, differentiated plant cells (such as cultured plantlets), transgeinic plants, and mature plants. Also included are in vitro expression systems such as reconstituted expression medium composed of components required to support transcription, as are known in the art.
By “enhancer domain” is meant a nucleic acid sequence that, when positioned proximate to a promoter and present in a transcription medium capable of supporting transcription, confers increased ex
Nielsen Mark T.
Xu Dongmei
Chunduru Prabha
Clark & Elbing LLP
Fredman Jeffrey
Profigen, Inc.
LandOfFree
Duplicated cassava vein mosaic virus enhancers and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Duplicated cassava vein mosaic virus enhancers and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Duplicated cassava vein mosaic virus enhancers and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3160978